Biofeedback Assisted Relaxation in Essential Hypertension : Short Term Follow-up of Contributing Effects to Pharmacotherapy on Blood Pressure and Heart Rate - "Brief Communication"

Basit Öğe Kaydı
dc.authorscopusid6603062229
dc.authorscopusid55908979100
dc.authorscopusid7004461946
dc.authorscopusid6602989167
dc.contributor.authorCengiz E.
dc.contributor.authorÜnalan H.
dc.contributor.authorTu?rul A.
dc.contributor.authorEkerbiçer H.
dc.date.accessioned2024-06-12T10:25:59Z
dc.date.available2024-06-12T10:25:59Z
dc.date.issued1997
dc.description.abstractThe present study was designed to evaluate the possible beneficial effects of biofeedback-assisted relaxation to pharmacotherapy on blood pressure and heart rate in patients with essential hypertension. Twenty patients with essential hypertension and without any complications or end-organ damage participated in the study. All the patients were using anti-hypertensive drugs. The study protocol consisted of an interview, 10 days baseline, 10 biofeedback-assisted relaxation sessions and a 10-day post-treatment period. Interview blood pressure (BP) and heart rate (HR) measurements, baseline mean values of systolic blood pressure (SBP), diastolic blood pressure (DBP) and HR recorded during the 1st, 10th and 20th minutes of each session and the post-treatment mean values were evaluated. Significant differences were found between the mean values of SBP, DBP and HR after the whole treatment protocol (Wilcoxon signed-ranks test). The mean values of SBP, DBP and HR measurements recorded during the 1st, 10th and 20th minutes of the biofeedback-assisted relaxation sessions, which were evaluated by repeated measures of ANOVA on ranks test, showed a significant decrease only for the 10th minute values at the end of the whole treatment program. Despite a short follow-up, it was suggested that these results were encouraging considering the fact that once the patients are thoroughly instructed in home practice of relaxation and encouraged to develop their own strategies for relaxation, the long term outcome may also be promising.en_US
dc.identifier.doi10.3349/ymj.1997.38.2.86
dc.identifier.endpage90en_US
dc.identifier.issn0513-5796
dc.identifier.issue2en_US
dc.identifier.pmid9175485en_US
dc.identifier.scopus2-s2.0-0030967334en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage86en_US
dc.identifier.urihttps://doi.org/10.3349/ymj.1997.38.2.86
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16619
dc.identifier.volume38en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherYonsei University College of Medicineen_US
dc.relation.ispartofYonsei Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBiofeedback; Essential Hypertensionen_US
dc.subjectAmlodipine; Enalapril; Adult; Aged; Article; Clinical Article; Controlled Study; Essential Hypertension; Feedback System; Female; Follow Up; Heart Rate; Human; Male; Oral Drug Administrationen_US
dc.titleBiofeedback Assisted Relaxation in Essential Hypertension : Short Term Follow-up of Contributing Effects to Pharmacotherapy on Blood Pressure and Heart Rate - "Brief Communication"en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu